Search
Advanced Search
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2020
New Titles 2019
Price and Ordering Information
Subscription Rates 2020
Subscription Rates 2019
eBooks Website
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Bentham Online
Accessibility Of Content
Bentham Insight
Online Feedback
Purchase Articles
Search Articles
Social Media
Submit Manuscripts
Marketing Opportunities
Advertise With Us
Journals and eBooks Catalog
Media-Pack-2019
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Kudos
Media Partners
Partnering Events
Promotional Services
For Librarians
FAQs for e-prints/reprints
Journal Catalog 2019
Journal Catalog 2020
Library Recommendations
Order Bulk ePrints
Order Bulk Reprints
Table of Contents Alert
Trial Requests
For Authors & Editors
Author Benefits
Author Reprints
Author's Benefits Guide
Copyediting Services
Editorial Policies
General FAQs
Guidelines for Guest Editors
Manuscript Transfer Facility
Online Manuscript Submission
Journal Catalog 2019
Journal Catalog 2020
Publication Cycle - Process Flowchart
Publishing Ethics
Peer Review
Self-Archiving Policies
Table of Contents Alert
Contact Us
Current Cancer Drug Targets
Volume 19, 11 Issues, 2019
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Impact Factor:
2.72
5 Year Impact Factor:
3.238
Ranking and Category
135
th
of
229
in
Oncology
Order Your Article Before Print
Join as Executive Guest Editor
Become a Reviewer
Join Editorial Board
Submit Book Proposal
Thematic Issue Proposal
Submit Abstract Online
Contents
Current Cancer Drug Targets
,
Volume 7
- Number 1
Editorial [Hot Topic: Molecular Mechanisms and Therapeutic Reversal of Immune Suppression in Cancer (Guest Editor: Dmitry I. Gabrilovich)]
,
7
(
1
):
1
Dmitry I. Gabrilovich
DOI:
10.2174/1568009610707010001
Permissions
Order Reprints
Order Eprints
Mechanisms of T Cell Tolerance and Suppression in Cancer Mediated by Tumor-Associated Antigens and Hormones
,
7
(
1
):
3
- 14
Adam J. Adler
DOI:
10.2174/156800907780006931
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Costimulation, Coinhibition and Cancer
,
7
(
1
):
15
- 30
Brant A. Inman, Xavier Frigola, Haidong Dong and Eugene D. Kwon
DOI:
10.2174/156800907780006878
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Indoleamine 2,3-Dioxygenase in Immune Suppression and Cancer
,
7
(
1
):
31
- 40
Alexander J. Muller and George C. Prendergast
DOI:
10.2174/156800907780006896
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Cellular and Molecular Mechanisms of Tumor-Induced T-Cell Tolerance
,
7
(
1
):
41
- 53
Pedro Horna and Eduardo M. Sotomayor
DOI:
10.2174/156800907780006940
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
T Cell Costimulatory and Inhibitory Receptors as Therapeutic Targets for Inducing Anti-Tumor Immunity
,
7
(
1
):
55
- 70
Jeurgen Foell and Becker Hewes
DOI:
10.2174/156800907780006841
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Targeting of Jak/STAT Pathway in Antigen Presenting Cells in Cancer
,
7
(
1
):
71
- 77
Yulia Nefedova and Dmitry I. Gabrilovich
DOI:
10.2174/156800907780006887
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Mechanisms Used by Human Papillomaviruses to Escape the Host Immune Response
,
7
(
1
):
79
- 89
Shreya Kanodia, Laura M. Fahey and W. Martin Kast
DOI:
10.2174/156800907780006869
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Small Molecule Inhibitors of Stat3 Signaling Pathway
,
7
(
1
):
91
- 107
Jinxia Deng, Fedora Grande and Nouri Neamati
DOI:
10.2174/156800907780006922
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Anatomic Site-Related Expression of Cancer-Associated Molecules in Ovarian Carcinoma
,
7
(
1
):
109
- 120
Ben Davidson
DOI:
10.2174/156800907780006904
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
About the Journal
⇨ Journal Home
⇨ Editorial Policies
⇨ Editorial Board
⇨ Meet the Executive Guest Editor(s)
⇨ Reviewer Board
⇨ Board Recruitment Workflow
⇨ Join Editorial Board
⇨ Indexing Information
⇨ Announcements
⇨ Endorsements
⇨ Authors' Comments
For Authors
⇨ Author Guidelines
⇨ Animated Abstracts
⇨ Submit Abstracts Online
⇨ Submit Manuscripts Online
⇨ Open Access Funding
⇨ Publishing Ethics and Rectitude
⇨ Self-Archiving Policies
⇨ Manuscript Transfer Facility
For Guest Editors
⇨ Thematic Issue Proposal
⇨ Forthcoming Thematic Issues
⇨ Guest Editor Guidelines
For Reviewers
⇨ Reviewer Guidelines
⇨ Peer Review Workflow
⇨ Become a Reviewer
For Librarians & Readers
⇨ Contents & Abstracts
⇨ Open Access Articles
⇨ Free Copies Online
⇨ Thematic Issues
⇨ Journal Catalog 2019
⇨ Journal Catalog 2020
⇨ Most Accessed Articles
⇨ PURCHASE ARTICLES
⇨ Order Reprints
⇨ Subscribe
⇨ Trial Requests
⇨ Library Recommendation
Quick Links
⇨ Journal's New Website
⇨ Advertise with Us
⇨ Brand Ambassadors
⇨ Download PDF Flyer
⇨ Table of Contents Alert
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Track Your Manuscript:
Enter Correct Manuscript Reference Number:
Submit Reference Number
Scopus CiteScore Metrics:
2.26
Advertisement
Related Journals
view more >>
Related eBooks
view more >>
eBooks Catalog
view eBooks Catalog >>
Webmaster Contact:
info@benthamscience.net
Copyright © 2019 Bentham Science
|
Privacy Policy